DIAGNOSTIC PECULARITIES OF METASTASES IN ASCITIC AND PLEURAL FLUID WITH THE USE OF IMMUNOCYTOCHEMICAL METHOD IN PATIENTS WITH SEROUS OVARY CANCER
- 作者: Grigoruk O.G1,2,3, Bogatyrev V.N4, Bazulina L.M2,3, Maksimenko T.A1,2,3, Lazarev A.F1,2,3
-
隶属关系:
- Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
- Altai Oncological Hospital, 656049, Barnaul, Russian Federation
- 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
- N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
- 期: 卷 18, 编号 1 (2013)
- 页面: 4-9
- 栏目: Articles
- ##submission.datePublished##: 15.02.2013
- URL: https://rjonco.com/1028-9984/article/view/39934
- DOI: https://doi.org/10.17816/onco39934
- ID: 39934
如何引用文章
全文:
详细
全文:
Особенности диагностики метастаза серозного рака яичника в асцитической и плевральной жидкостях с использованием иммуноцитохимического метода作者简介
O. Grigoruk
Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences; Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences
Email: cytolakod@rambler.ru
656049, Barnaul, Russian Federation
V. Bogatyrev
N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences115478, Moscow, Russian Federation
L. Bazulina
Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
T. Maksimenko
Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences; Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
A. Lazarev
Altay branch of N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences; Altai Oncological Hospital, 656049, Barnaul, Russian Federation ; 3N.N.Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
参考
- Карселадзе А. И. Клинико-морфологическая диагностика опухолей яичника. Архив патологии 2005; прил.: 63.
- Alberti N., Serrano-Egea A., Garcia-García E. et al. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry. Acta Cytol. 2007; 51 (2): 203—206.
- Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008; 9: 1191—1197.
- Davidson B. The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma. Cytopathology. 2011; 22: 5—21.
- Capitanio A., Natula A., Falson M. Diagnostic pitfall of atipical glandular cells with psammoma bodies in peritoneal waching cytology. J. Cytopathol. 2008, 19 (Suppl. 1: 34th European Congress of Cytology, Rovaniemi, Finland): poster 108; 56.
- Григорук О. Г., Лазарев А. Ф., Богатырёв В. Н. Дифференциальная цитологическая диагностика плевритов. Барнаул: ОАО «ИПП "Алтай"», 2012: 122—4.
- Comin C.E., Saieva C., Messerini L. H-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am. J. Surg. Pathol. 2007; 31 (8): 1139—48.
- McCluggage W. G., Young R. H. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin. Diagn. Pathol. 2005; 22 (1): 3—32.
- Politi E., Kandaraki C., Apostolopoulou C. et al. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn. Cytopathol. 2005; 32: 151—5.
- Su X. Y., Li G. D., Liu W. P. et al. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn. Cytopathol. 2010; 10: 123—7.
- Мельник М. М. Імуногістохімічні технології діагностики метастазів анонімної пухлин. Світ медицини та біології. 2008; 2: 48—56.
- Tot T. Cytokeratyns 20 and 7 as biomarkers usefulness in discriminating primary from metastatic adenocarcinoma. Eur. J. Cancer. 2002; 38 (6): 758—63.
- Heintz A. P., Odicino F., Maisonneuve P. et al. Carcinoma of the ovary FIGO. Int. J. Gynaecol. Obstetr. 2006; 95 (Suppl. 1: 6th Annual report on the results of treatment in gynecological cancer): 161—92.
- Hylander B., Repasky E., Shrikant P. et al. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol. Oncol. 2006; 101: 12—7.
- Zhu W., Michael C. Wt1, Monoclonal CEA, TTF1, and CA125 antibodies in the differencial diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn. Cytopathol. 2007; 35 (6): 370—5.
- Sopel M., Surowiak P., Berdowska I. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. Folia Morphol. 2010; 69 (4): 204—12.
补充文件
![](/img/style/loading.gif)